Business Context and Reporting Period
Company: NeuroOne Medical Technologies Corporation (NMTC)
Filing Type: Form 8-K (Current Report)
Report Date: December 17, 2025
Reporting Period: Fiscal quarter and fiscal year ended September 30, 2025
This filing serves to announce the issuance of a press release detailing the Company's financial results for the period ended September 30, 2025. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Specific values for revenue, profit, cash flow, margins, debt, and liquidity are not available in the source text.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only confirms that results for the quarter and year ended September 30, 2025, have been announced.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release issued on December 17, 2025, but does not include the text of that commentary.
Legal Disclaimer: The information in Item 2.02 is furnished, not "filed," under Section 18 of the Exchange Act and is not subject to the liabilities of that section unless expressly incorporated by reference in other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated December 17, 2025) for specific revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter growth rates in the full press release.
- Check for any updated forward-looking guidance or operational milestones mentioned in the press release.
- Confirm the status of the Company's liquidity and working capital as detailed in the full financial results.